OPKO Health to buy 45% of Israeli hepatitis B vaccine producer
US drug maker OPKO Health Inc (NYSE:OPK) said it has agreed a deal to acquire 45% of an unnamed privately-held Israeli firm, which manufactures a third-generation hepatitis B vaccine, for…

